|
Volumn 1, Issue 3, 2006, Pages 209-218
|
The severity of airways obstruction as a determinant of treatment response in COPD.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
PLACEBO;
AGED;
ARTICLE;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
DOSE RESPONSE;
DRUG TOXICITY;
FEMALE;
HEALTH STATUS;
HOSPITALIZATION;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
LUNG FUNCTION TEST;
MALE;
MIDDLE AGED;
OUTCOME ASSESSMENT;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
UNITED KINGDOM;
ADMINISTRATION, INHALATION;
ADRENERGIC BETA-AGONISTS;
AGED;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG TOXICITY;
FEMALE;
GREAT BRITAIN;
HEALTH STATUS;
HUMANS;
MALE;
MIDDLE AGED;
OUTCOME ASSESSMENT (HEALTH CARE);
PLACEBOS;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
QUESTIONNAIRES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RESPIRATORY FUNCTION TESTS;
SEVERITY OF ILLNESS INDEX;
|
EID: 34547635199
PISSN: 11769106
EISSN: None
Source Type: Journal
DOI: 10.2147/copd.2006.1.3.209 Document Type: Article |
Times cited : (20)
|
References (0)
|